The cholesterol synthesis rate-limiting enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) was up-regulated in many tumors such as gastric cancer, glioma and prostate cancer. This evidence concerns the gene HMGCR and prostate carcinoma.